References

1.  Arowojolu AO, Okewole IA, Adekunle AO. Comparative evaluation of the
    effectiveness and safety of two regimens of levonorgestrel for
    emergency contraception in Nigerians. *Contraception*.
    2002;66:269-273.

2.  Belzer M, Yoshida E, Tejirian T, Tucker D, Chung K, Sanchez K.
    Advanced supply of emergency contraception for adolescent mothers
    increased utilization without reducing condom or primary
    contraception use. Research Presentations. *J of Adolesc Health*.
    2003;32:122-123.

3.  CRLP. Center for Reproductive Law and Policy. Citizen\'s Petition.
    Submitted to the FDA on February 14, 2001.
    <http://www.crlp.org/pdf/EC_petition.pdf> Accessed on November 12,
    2003.

4.  Croxatto H. Progress report to CONRAD Collaborative Center for
    Clinical Research. Report CIG-00-62. September 2002b.

5.  Croxatto HB, Fuentealba B, Brache V, et al. Effects of the Yuzpe
    regimen, given during the follicular phase, on ovarian function.
    *Contraception*. 2002c;65:121-128.

6.  Croxatto HB. Emergency contraception pills: how do they work? *IPPF
    Medical* *Bulletin* 2002d;36:1-2.

7.  Ellertson C, Ambardekar S, Hedley A, Coyaji K, Trussell J,
    Blanchard K. Emergency contraception: randomized comparison of
    advance provision and information only. *Obstet Gynecol*.
    2001a;98:570-575.

8.  Glasier A, Baird D. The effects of self-administering emergency
    contraception. *New Engl J Med*. 1998c;339:1-4.

9.  Glasier A. Emergency postcoital contraception. *New Engl J Med*.
    1997;337: 1058-1064.

10. Grimes DA, Raymond EG, Scott Jones B. Emergency contraception
    over-the-counter: the medical and legal imperatives. *Obstet
    Gynecol*. 2001;98:151-155.

11. Ho PC, Kwan MS. A prospective randomized comparison of
    levonorgestrel with the Yuzpe regimen in post-coital contraception.
    *Hum Reprod*. 1993;8:389-392.

12. Jones RK, Darroch JE, Henshaw SE. Contraceptive use among U.S. women
    having abortions in 2000-2001. *Perspec Sexual Reprod Health*.
    2002b;34:294-303.

13. Kahlenborn C, Stanford JB, Larimore WL. Postfertilization effect of
    hormonal emergency contraception. *Ann Pharmacother*.
    2002;36:465-70.

14. Kaiser Family Foundation. A national survey of women about their
    sexual health. *Self* *Magazine*. Summer 2003a.

15. Kaiser Family Foundation. National survey of women's health care
    providers on reproductive health: emergency contraception. June
    2003b.

16. Kaiser Family Foundation. Lifetime Television, Vital Signs Inde No.
    2: Emergency contraception (selected findings). November 2000.

17. Kook K, Gabelnick H, Duncan G. Pharmacokinetics of levonorgestrel
    0.75 mg tablets. *Contraception*. 2002;66:73-76.

18. McCann MF, Potter LS. Progestin-only oral contraception: a
    comprehensive review. Ectopic pregnancies. *Contraception*.
    1994;50(Suppl 1):S44-49.

19. MMWR. Youth Risk Behavior Surveillance -- United States, 2001. *MMWR
    Morbid Mortal Wkly Rep*. June 28, 2002; 51(SS04);1-64.

20. Müller AL, Llados CM, Croxatto HB. Postcoital treatment with
    levonorgestrel does not disrupt postfertilization events in the rat.
    *Contraception*. 2003;67:415-419.

21. ní Riain A. Increasing the effectiveness of contraceptive usage in
    university students. *Eur J Contracept Reprod Health Care*.
    1998;3:124-128.

22. Peterson LS. Contraceptive use in the United States: 1982-90. Vital
    and Health Statistics of the Centers for Disease Control and
    Prevention. *Advance Data*. 1995;260:1-15.

23. Piaggio G, von Hertzen H, Grimes DA, Van Look PF. Timing of
    emergency contraception with levonorgestrel or the Yuzpe regimen
    \[letter\]. *Lancet*. 1999; 353:721.

24. Raine T, Harper C, Leon K, Darney P. Emergency Contraception:
    Advance provision in a young, high-risk clinic population. *Obstet
    Gynecol*. 2000;96:1-7.

25. Raymond EG, Dalebout SM, Camp SI. Comprehension of a prototype
    over-the-counter label for an emergency contraceptive pill product.
    *Obstet Gynecol*. 2002a; 100:342-349.

26. Roye CF, Johnsen JRM. Adolescent and emergency contraception. *J
    Pediatr Health Care*. 2002;16:3-9.

27. Roye CF. Routine provision of emergency contraception to teens and
    subsequent condom use: a preliminary study \[letter\]. *J Pediatr
    Health Care*. 2001;28:165-166.

28. Sucato GS, Gardner JS, Koepsell TD. Adolescents' use of emergency
    contraception provided by Washington state pharmacists. *J Pediatr
    Adolesc Gynecol*. 2001;14:163-169.

29. Trussell J, Stewart F, Guest F, Hatcher RA. Emergency contraceptive
    pills: a simple proposal to reduce unintended pregnancies. *Fam
    Plann Perspect*. 1992b; 24:269-273.

30. Trussell J, Ellertson C, Dorflinger L. Effectiveness of the Yuzpe
    regimen of emergency contraception by cycle day of intercourse:
    implications for mechanism of action. *Contraception*.
    2003c;67:167-171. (Preprint Trussell 2002)

31. UCSF. University of California, San Francisco. Results of the
    analysis of provision of emergency contraception to women enrolled
    in the study prior to December 31, 2001: Pharmacy access and advance
    distribution evaluation. Study #H9738-18501-02. Report prepared by
    PinneyAssociates. January 30, 2003b.

32. Ugocsai G, Rózsa M, Ugocsai P. Scanning electron microscopic (SEM)
    changes of the endometrium in women taking high doses of
    levonorgestrel as emergency postcoital contraception.
    *Contraception*. 2002;66:433-437.

33. United States Census Bureau. U.S. Summary: 2000. Census 2000
    Profile. Issued July 2002.

34. Van Look PFA, von Hertzen H. Emergency contraception. *Br Med Bull*.
    1993;49: 158-170.

35. van Royen AR, Calvin CK, Lightner CR. Knowledge and attitudes about
    emergency contraception in a military population. *Obstet Gynecol*.
    2000;96:921-925.

36. VHS. Fertility, Family Planning, and Women\'s Health: New Data From
    the 1995 National Survey of Family Growth. *Vital and Health
    Statistics*. Series 23. No. 19. May 1997. Available at:
    <http://www.cdc.gov/nchs/data/series/sr_23/sr23_019.pdf>. Accessed
    November 12, 2003.

37. WCC/FHI, Women's Capital Corporation and Family Health
    International. Plan B Over-the-Counter Label Comprehension Study
    Report. FHI Study #9728. Final Study Report. November 5, 2001.

38. WCC/FHI,Women's Capital Corporation and Family Health International.
    Plan B OTC Actual Use Study. Phase 3. Non-comparative case series
    study of Plan B levonorgestrel emergency contraceptive pills
    provided using a simulated over-the-counter approach. FHI Study
    #9727. Final Study Report. 2002. (Updated 2003)

39. Wells ES, Hutchings J, Gardner JS, et al. Using pharmacists in
    Washington State to expand access to emergency contraception. *Fam
    Plann Perspect*. 1998;30:288-290.

40. WHO #92908. Report of the pivotal study: A prospective, randomized,
    multi-center study to compare the Yuzpe regimen with levonorgestrel
    in emergency postcoital contraception. November 15, 1998. Published.
    Task Force on Postovulatory Methods of Fertility Regulation.
    Randomised controlled trial of levonorgestrel versus the Yuzpe
    regimen of combined oral contraceptives for emergency contraception.
    *Lancet* 1998b;352:428-433.

41. WHO Task Force on Post-Ovulatory Methods for Fertility Regulation.
    United Nations Development Programme/ United Nations Population
    Fund/World Health Organization/World Bank Special Programme of
    Research, Development and Research Training in Human Reproduction.
    Efficacy and side effects of immediate postcoital levonorgestrel
    used repeatedly for contraception. *Contraception* 2000a; 61:
    303-308.

42. WHO Research Group on Post-ovulatory Methods of Fertility
    Regulation. Published. von Hertzen H, Piaggio G, Ding J, et al. Low
    dose mifepristone and two regimens of levonorgestrel for emergency
    contraception: a WHO multicentre randomised trial. *Lancet*. 2002;
    360:1803-1810.

43. Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual intercourse in
    relation to ovulation: effects on the probability of contraception,
    survival of the pregnancy, and sex of the baby. *New Engl J Med*.
    1995;333:1517-1521.

44. Wu S, Wang C, Wang Y. \[A randomized, double-blind, multicentre
    study on comparing levonorgestrel and mifepristone for emergency
    contraception\] \[Chinese\]. *Zhonghua Fu Chan Ke Za Zhi*.
    1999;34:327-330. \[Full text in Chinese available upon request\]

45. Yeung WSB, Chiu PCN, Wang CH, Yao YQ, Ho P-C. The effects of
    levonorgestrel on various sperm functions. *Contraception*.
    2002;66:453-457.

46. Downing D. Pharmacist prescribing of emergency contraception: the
    Washington State experience. Emergency contraception the
    pharmacist's role. *APhA Special Report*. Available at:
    http://www.pharmacist.com/pdf/emer\_ contra.pdf Accessed on November
    12, 2003